https://assets.capyfin.com/instruments/678fdc13234e27009c5d5858.png avatar
Thermo Fisher
🇺🇸 NYSE:TMO
View Company
OverviewEarningsDividends
•
Dec 31, 2020

Thermo Fisher Q4 2020 Earnings Report

Thermo Fisher Scientific reported strong growth in revenue, earnings, and free cash flow, driven by the societal response to the pandemic and momentum in the base business.

Key Takeaways

Thermo Fisher Scientific Inc. reported a significant increase in its financial performance for the fourth quarter and full year ended December 31, 2020. The company's fourth-quarter revenue grew by 54% to $10.55 billion, with GAAP diluted EPS increasing by 151% to $6.24 and adjusted EPS increasing by 100% to $7.09.

Fourth quarter revenue grew 54% to $10.55 billion.

Fourth quarter GAAP diluted earnings per share (EPS) increased 151% to $6.24.

Fourth quarter adjusted EPS increased 100% to $7.09.

Generated $3.2 billion of COVID-19 response revenue and accelerating growth momentum in the base business.

Total Revenue
$10.6B
Previous year: $6.83B
+54.5%
EPS
$7.09
Previous year: $3.55
+99.7%
Organic Revenue Growth
51%
Previous year: 5%
+920.0%
Adjusted Operating Margin
33.3%
Previous year: 24.9%
+33.7%
Gross Profit
$5.68B
Previous year: $3.16B
+79.9%
Cash and Equivalents
$10.3B
Previous year: $2.4B
+330.4%
Free Cash Flow
$2.75B
Previous year: $1.64B
+67.7%
Total Assets
$69.1B
Previous year: $58.2B
+18.7%

Thermo Fisher

Thermo Fisher

Thermo Fisher Revenue by Segment

Forward Guidance

The company will provide 2021 financial guidance during its earnings conference call this morning at 8:30 a.m. Eastern time.

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Company Overview

Full financial data and analysis

View Thermo Fisher